World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
100
Citations
37060
World Ranking
8272
National Ranking
4282

Wendy B. London publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Wendy B. London sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 386 publications — 35th percentile

35% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Wendy B. London D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Wendy B. London sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 100 D-Index — 60th percentile

60% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Wendy B. London is affiliated with Harvard University in the United States and has a body of work primarily in the fields of Medicine and Biochemistry, Genetics and Molecular Biology. Their research spans significant topics in neurology, genetics, oncology, molecular biology, and cancer research.

Their publication record includes numerous papers focused on neuroblastoma as well as broader cancer research topics. Key research topics covered in their work include:

  • Neuroblastoma Research and Treatments
  • Cancer, Hypoxia, and Metabolism
  • Glioma Diagnosis and Treatment
  • Cancer Therapeutics and Mechanisms
  • Lung Cancer Research Studies
  • Neurofibromatosis and Schwannoma Cases
  • Blood Groups and Transfusion

London has frequently published in a set of specific research journals, demonstrating an ongoing engagement with clinical and cancer-related research communities. The most common venues for their publications are:

  • Journal of Clinical Oncology
  • Pediatric Blood & Cancer
  • Blood
  • Transplantation and Cellular Therapy
  • Cancer Medicine

Their list of frequent collaborators includes the following researchers:

  • Pei-Chi Kao
  • Arlene Naranjo
  • Steven G. DuBois
  • Rochelle Bagatell
  • Julie R. Park

Among their recent papers, the following stand out for their focus and publication venues:

  • "Revised Neuroblastoma Risk Classification System: A Report From the Children's Oncology Group," 2021, Journal of Clinical Oncology
  • "Post-Transcriptional Genetic Silencing of BCL11A to Treat Sickle Cell Disease," 2020, New England Journal of Medicine
  • "Long-Term Follow-up of a Phase III Study of ch14.18 (Dinutuximab) + Cytokine Immunotherapy in Children with High-Risk Neuroblastoma: COG Study ANBL0032," 2021, Clinical Cancer Research
  • "Irinotecan, Temozolomide, and Dinutuximab With GM-CSF in Children With Refractory or Relapsed Neuroblastoma: A Report From the Children's Oncology Group," 2020, Journal of Clinical Oncology
  • "Age, Diagnostic Category, Tumor Grade, and Mitosis-Karyorrhexis Index Are Independently Prognostic in Neuroblastoma: An INRG Project," 2020, Journal of Clinical Oncology

Best Publications

  • Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma

    Alice L. Yu;Andrew L. Gilman;M. Fevzi Ozkaynak;Wendy B. London

  • The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report

    Susan L. Cohn;Andrew D.J. Pearson;Wendy B. London;Tom Monclair

  • The genetic landscape of high-risk neuroblastoma

    Trevor J Pugh;Olena Morozova;Edward F Attiyeh;Edward F Attiyeh;Shahab Asgharzadeh;Shahab Asgharzadeh

  • The International Neuroblastoma Risk Group (INRG) Staging System: An INRG Task Force Report

    Tom Monclair;Garrett M. Brodeur;Peter F. Ambros;Hervé J. Brisse

  • Long-Term Results for Children With High-Risk Neuroblastoma Treated on a Randomized Trial of Myeloablative Therapy Followed by 13-cis-Retinoic Acid: A Children's Oncology Group Study

    Katherine K. Matthay;C. Patrick Reynolds;Robert C. Seeger;Hiroyuki Shimada

  • Activating mutations in ALK provide a therapeutic target in neuroblastoma

    Rani E. George;Takaomi Sanda;Megan C. Hanna;Stefan Fröhling

  • Advances in Risk Classification and Treatment Strategies for Neuroblastoma

    Navin R. Pinto;Mark A. Applebaum;Samuel L. Volchenboum;Katherine K. Matthay

  • Chromosome 1p and 11q deletions and outcome in neuroblastoma.

    Edward F. Attiyeh;Wendy B. London;Yael P. Mossé;Qun Wang

  • Evidence for an Age Cutoff Greater Than 365 Days for Neuroblastoma Risk Group Stratification in the Children's Oncology Group

    W.B. London;R.P. Castleberry;K.K. Matthay;A.T. Look

  • Dexrazoxane-associated risk for acute myeloid leukemia/myelodysplastic syndrome and other secondary malignancies in pediatric Hodgkin's disease

    Cameron K. Tebbi;Wendy B. London;Debra Friedman;Doojduen Villaluna

  • Guidelines for Imaging and Staging of Neuroblastic Tumors: Consensus Report from the International Neuroblastoma Risk Group Project

    Hervé J. Brisse;M. Beth McCarville;Claudio Granata;K. Barbara Krug

  • A Modified γ-Retrovirus Vector for X-Linked Severe Combined Immunodeficiency

    Salima Hacein-Bey-Abina;Sung Yun Pai;H. Bobby Gaspar;Myriam Armant

  • International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee.

    PF Ambros;IM Ambros;GM Brodeur;M Haber

  • Copy number variation at 1q21.1 associated with neuroblastoma

    Sharon J. Diskin;Cuiping Hou;Joseph T. Glessner;Edward F. Attiyeh;Edward F. Attiyeh

  • Clinicopathologic Features and Long-term Outcomes of NUT Midline Carcinoma

    Daniel E. Bauer;Chelsey M. Mitchell;Kelly M. Strait;Christopher S. Lathan

  • Children's Oncology Group's 2013 blueprint for research: Neuroblastoma

    Julie R. Park;Rochelle Bagatell;Wendy B. London;John M. Maris

  • ALK mutations confer differential oncogenic activation and sensitivity to ALK inhibition therapy in neuroblastoma

    Scott C. Bresler;Daniel A. Weiser;Daniel A. Weiser;Peter J. Huwe;Jin H. Park

  • Common variations in BARD1 influence susceptibility to high-risk neuroblastoma

    Mario Capasso;Marcella Devoto;Cuiping Hou;Shahab Asgharzadeh

  • Outcome and Staging Evaluation in Malignant Germ Cell Tumors of the Ovary in Children and Adolescents: An Intergroup Study

    D Billmire;C Vinocur;F Rescorla;B Cushing

  • Outcome after Reduced Chemotherapy for Intermediate-Risk Neuroblastoma

    David L. Baker;Mary L. Schmidt;Susan L. Cohn;John M. Maris

Frequent Co-Authors

Susan L. Cohn
Susan L. Cohn University of Chicago
John M. Maris
John M. Maris Children's Hospital of Philadelphia
Katherine K. Matthay
Katherine K. Matthay University of California, San Francisco
Michael D. Hogarty
Michael D. Hogarty Children's Hospital of Philadelphia
Robert C. Seeger
Robert C. Seeger Children's Hospital of Los Angeles
Hiroyuki Shimada
Hiroyuki Shimada Stanford University
Peter F. Ambros
Peter F. Ambros St Anna Children's Hospital
Andrew D.J. Pearson
Andrew D.J. Pearson Royal Marsden NHS Foundation Trust
Alice L. Yu
Alice L. Yu University of California, San Diego
Julie M. Gastier-Foster
Julie M. Gastier-Foster Baylor College of Medicine

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Medicine in the USA opens up diverse paths beyond a traditional MD. Online degree options have expanded rapidly, making healthcare careers more accessible and flexible for students with busy schedules or those looking for faster, affordable routes.

Pharmacy is a high-demand field, and a 3-year online pharmd enables you to earn a doctorate in pharmacy entirely online, combining convenience with advanced qualification. For those interested in healthcare administration, an online bachelor's in health information management is a smart choice, preparing you for roles managing medical records and data systems in hospitals and clinics.

If you prefer the administrative side, earning a medical coding certification online offers a quick and affordable way to start working in healthcare facilities, insurance companies, or remote positions. Meanwhile, nurses seeking career advancement can enroll in the cheapest online acute care nurse practitioner programs for specialized clinical training and higher earning potential.

Whether you’re interested in direct patient care, administration, or health technology, online degrees offer multiple affordable entry points to a rewarding healthcare career.

Best Scientists Citing Wendy B. London

Trending Scientists

Recently Published Articles